Home›Compare›MangoRx vs yourEra

MangoRx vs yourEra: Which Is Better?

Head-to-head comparison of MangoRx and yourEra based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

yourEra scores higher overall in our independent evaluation (65.1/100 vs 58/100), leading on trust & safety, value, experience, reputation. MangoRx comes out ahead on product range. MangoRx has the lower entry price (from $50/mo vs $79/mo), so the better value depends on which treatment you need.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
65

yourEra is a physician-founded telehealth brand based in Covington, LA. It offers compounded semaglutide, tirzepatide, microdosed GLP-1s, NAD+ and sermorelin, and names its medical group and dispensing pharmacies.

Visit yourEra

Score Breakdown

DimensionMangoRxyourEra
Overall Score58/10065.1/100 ✓
Trust & Safety30%55/10068/100 ✓
Value25%62/10072/100 ✓
Experience20%58/10062/100 ✓
Product Range15%66/100 ✓62/100
Reputation10%45/10050/100 ✓

At a Glance

Founded2021—
HeadquartersDallas, TXCovington, LA
Publicly tradedYes (MGRX)No
Treatment categories52
Treatments listed55
Starting price$50/mo$79/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxyourEra
Weight Loss / GLP-1$299
Slim (compounded oral semaglutide ODT)
$79–$179
Compounded Semaglutide

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

yourEra

+Names its operating entity, medical group (Thryv Telehealth by Lavin, P.C.) and all three dispensing pharmacies in its terms
+Card is charged only after a clinician issues a prescription, and members can cancel from the dashboard without calling
+Covers GLP-1s plus microdosed GLP-1 protocols, NAD+ and sermorelin under one account
−Advertised prices differ across the brand's own landing pages ($79–159 semaglutide, $159–239 tirzepatide), so the real monthly rate depends on plan length and entry page
−Almost no independent review footprint; ratings shown are on-site only
−State exclusions are not published; terms only say service is limited to states where it operates
Read the full yourEra review →

MangoRx vs yourEra — FAQ

Is MangoRx better than yourEra?

▾

yourEra scores higher overall in our independent evaluation (65.1/100 vs 58/100), leading on trust & safety, value, experience, reputation. MangoRx comes out ahead on product range. MangoRx has the lower entry price (from $50/mo vs $79/mo), so the better value depends on which treatment you need.

Is MangoRx or yourEra cheaper?

▾

MangoRx has the lower starting price (from $50/mo vs $79/mo for yourEra). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and yourEra both offer?

▾

Both platforms treat Weight Loss / GLP-1. MangoRx covers 5 treatment categories total and yourEra covers 2.

Still deciding?